4//SEC Filing
ELITE PHARMACEUTICALS INC /NV/ 4
Accession 0001467874-16-000001
$ELTPCIK 0001053369operating
Filed
May 2, 8:00 PM ET
Accepted
May 3, 11:50 AM ET
Size
7.3 KB
Accession
0001467874-16-000001
Insider Transaction Report
Form 4
Ward Carter Julian
Chief Financial Officer
Transactions
- Conversion
Common Stock
2016-04-28$0.06/sh+666,667$41,667→ 1,752,285 total - Conversion
Warrants
2016-04-28−666,667→ 0 totalExercise: $0.06From: 2009-06-03Exp: 2016-06-03→ Common Stock (666,667 underlying)
Holdings
- 1,355,014(indirect: By IRA)
Common Stock
Documents
Issuer
ELITE PHARMACEUTICALS INC /NV/
CIK 0001053369
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0001053369
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 11:50 AM ET
- Size
- 7.3 KB